Rapid Micro Biosystems
RPID
55 hedge funds and large institutions have $228M invested in Rapid Micro Biosystems in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 7 closing their positions.
120% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 10
114% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 7
12% more funds holding
Funds holding: 49 → 55 (+6)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.41% less ownership
Funds ownership: 63.64% → 62.22% (-1.4%)
43% less capital invested
Capital invested by funds: $401M → $228M (-$173M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.37M |
| 2 |
State Street
Boston,
Massachusetts
|
+$4.15M |
| 3 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$3.06M |
| 4 |
JP Morgan Chase
New York
|
+$1.59M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$1.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$11.4M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$9.44M |
| 3 |
CCM
CAAS Capital Management
New York
|
-$3.31M |
| 4 |
Jennison Associates
New York
|
-$2.28M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.11M |
RPID Hedge Fund Activity: Q4 2021 in Review
55 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Rapid Micro Biosystems (RPID) for Q4 2021, worth a combined $228M — down 43% from $401M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new RPID positions and 7 closed out — a net gain of 8 holders — while 22 added to existing stakes and 10 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $5.37M. The largest seller was Vanguard Group, cutting an estimated $11.4M.
- 55 institutional investors held Rapid Micro Biosystems (RPID) as of Q4 2021, up from 49 in Q3 2021.
- Funds reported $228M of Rapid Micro Biosystems stock for Q4 2021, down 43% quarter-over-quarter.
- 15 funds opened new Rapid Micro Biosystems positions in Q4 2021 and 7 closed out, a net change of +8 holders.
- The largest Rapid Micro Biosystems buyer in Q4 2021 was T. Rowe Price Associates, an estimated $5.37M added.
- The largest Rapid Micro Biosystems seller in Q4 2021 was Vanguard Group, an estimated $11.4M sold.
Based on aggregated 13F filings for Q4 2021.